Citation Impact

Citing Papers

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
The Cost-Utility of Sequential Adjuvant Trastuzumab in Women with Her2/Neu-Positive Breast Cancer: An Analysis Based On Updated Results from the HERA Trial
2009
Breast cancer
2016 Standout
Relaxin‐like peptides in cancer
2003
The Survival Benefits of AIDS Treatment in the United States
2006
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Wage Losses in the Year After Breast Cancer: Extent and Determinants Among Canadian Women
2008
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
2013 Standout
Early stage breast cancer: costs and quality of life one year after treatment by mastectomy or conservative surgery and radiation therapy
2000
Return-to-work interventions integrated into cancer care: a systematic review
2010 Standout
Perioperative Screening for Metastatic Disease is not Indicated in Patients with Primary Breast Cancer and no Clinical Signs of Tumor Spread
2003
Projections of Global Mortality and Burden of Disease from 2002 to 2030
2006 Standout
A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: A decision analysis
2011
Natural compounds for cancer treatment and prevention
2009 Standout
Body Image in Younger Breast Cancer Survivors
2015 Standout
Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-cell lung cancer
1999
Perspectives in cancer chemotherapy
2001
Importance of Faith on Medical Decisions Regarding Cancer Care
2003
The perceived effectiveness regarding Immersive Virtual Reality learning environments changes by the prior knowledge of learners
2020 Standout
Relaxin Augments BMP-2–Induced Osteoblast Differentiation and Bone Formation
2014 Standout
Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.
1997
Religion, Spirituality, and Health: The Research and Clinical Implications
2012 Standout
How good is the Prevent model for estimating the health benefits of prevention?
1999
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout

Works of B P Will being referenced

Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs
1999
Decision Framework for Chemotherapeutic Interventions for Metastatic Non-Small-Cell Lung Cancer
2000
Estimates of the lifetime costs of breast cancer treatment in Canada
2000
Diagnostic and therapeutic approaches to lung cancer in Canada and their costs
1995
Cost of combined modality interventions for stage III non-small-cell lung cancer.
1997
The economics of lung cancer management in Canada
1996
Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
1995
Rankless by CCL
2026